Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers

Daewoong Pharmaceutical

Status and phase: Unknown; Phase 1

Conditions: Healthy

Treatments: Drug: DWJ1392; Drug: DWC20164

Study type: Interventional

Funder types: Industry

Identifiers

NCT03016520

DW_DWJ1392001

Details and patient eligibility

About

The purpose of this study to Compare the safety and pharmacokinetics of DWJ1392 and DWC20164 in healthy male volunteers.

Enrollment: 28 estimated patients

Sex: Male

Ages: 19 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• No clinically significant findings
• Age 19-50 years at screening

Exclusion criteria

• Who has allergy to investigational product

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

28 participants in 2 patient groups

Test drug

Experimental group

Description:

DWJ1392

Treatment:

Drug: DWJ1392

Reference drug

Experimental group

Description:

DWC20164

Treatment:

Drug: DWC20164